BILL & MELINDA GATES FOUNDATION
We are excited about GHDDI’s potential to drive innovation in global health research and development, and look forward to partnering with Tsinghua University on our continued work to address the world’s most pressing global health challenges.
Co-Chair of the Bill & Melinda Gates Foundation
The establishment of GHDDI is an important effort by Tsinghua University to advance pharmaceutical research and translational medicine. I hope this initiative will facilitate the reform of pharmaceutical R&D system in China and impact global health.
PRESIDENT OF TSINGHUA UNIVERSITY
- In China and for the World: Global Health Drug Discovery Institute (GHDDI) Embarks on A New Journey of Innovative Drug Discovery 2018/11/07
- Global leadership of the Gates Foundation visits GHDDI to support its development 2018/07/17
- CEO of Gates Foundation visits Beijing to support the development of GHDDI 2017/09/28
GHDDI aims to become a major biomedical research center of excellence with a broad focus on translational research - from the bench to the bedside. Scientists at GHDDI work across a wide range of diseases that disproportionately affect populations in the developing world, including but not limited to tuberculosis, malaria, helminth infections, diarrheal disease, etc.LEARN MORE